Several countries including the US, the UK, and India may have vaccines against SARS-CoV-2 as soon as this year. With questions being raised about our readiness to distribute the vaccine going as far as the...
In an announcement today from the U.S. Department of Health and Human Services (HHS), licensed pharmacists are allowed to provide all vaccines recommended by the CDC's Advisory Committee on Immunization Practices (ACIP) to children aged 3 to 18
On the heels of Russia’s questionably early commencement of public production of the COVID-19 vaccine, leading SARS-CoV-2 vaccine manufacturers are quickly approaching the Thanksgiving vaccine moment.
Today Pfizer and BioNTech have jointly announced they are prepared to begin their Phase II/III global trials for their COVID-19 vaccine partnership. Following on review of Phase I/II trial results, the partnership worked with the FDA to select BNT162b2 as the vaccine candidate in the next phases.
Pfizer and BioNTech biopharmaceutics announced today a $1.95 billion dollar agreement with the U.S. government for 100 million doses of the partnership's BNT162 program vaccine.
In a press release from Oracle today, the computing and networking giant announced a partnership with The National Institute of Allergy and Infectious Diseases (NIAID) on a newly established COVID-19 Prevention Network or CoVPN.
Materials science company SiO2 issued a press release announcing a $143 million agreement with the US Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear...
We spoke with Pfizer today and confirmed October remains feasible but is contingent on successful aquisition of an Emergency Use Declaration